Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP): Protocol for a multicentre cluster randomised trial comparing a complex intervention for medication optimization against usual care.
Payne RA, Blair PS, Caddick B, Chew-Graham CA, Dreischulte T, Duncan LJ, Guthrie B, Mann C, Parslow RM, Round J, Salisbury C, Turner KM, Turner NL, McCahon D. Payne RA, et al. Among authors: turner nl. NIHR Open Res. 2022 Nov 8;2:54. doi: 10.3310/nihropenres.13285.1. eCollection 2022. NIHR Open Res. 2022. PMID: 37881305 Free PMC article.
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial.
Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G. Wiles N, et al. Lancet. 2013 Feb 2;381(9864):375-84. doi: 10.1016/S0140-6736(12)61552-9. Epub 2012 Dec 7. Lancet. 2013. PMID: 23219570 Clinical Trial.
Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G. Wiles N, et al. Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310. Health Technol Assess. 2014. PMID: 24824481 Free PMC article. Clinical Trial.
Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT).
Hewlett S, Almeida C, Ambler N, Blair PS, Choy EH, Dures E, Hammond A, Hollingworth W, Kadir B, Kirwan JR, Plummer Z, Rooke C, Thorn J, Turner N, Pollock J; RAFT Study Group. Hewlett S, et al. Ann Rheum Dis. 2019 Apr;78(4):465-472. doi: 10.1136/annrheumdis-2018-214469. Epub 2019 Feb 6. Ann Rheum Dis. 2019. PMID: 30793700 Free PMC article. Clinical Trial.
TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.
Ridd MJ, Edwards L, Santer M, Chalmers JR, Waddell L, Marriage D, Muller I, Roberts K, Garfield K, Coast J, Selman L, Clement C, Shaw ARG, Angier E, Blair PS, Turner NL, Taylor J, Kai J, Boyle RJ. Ridd MJ, et al. Among authors: turner nl. BMJ Open. 2019 May 9;9(5):e028428. doi: 10.1136/bmjopen-2018-028428. BMJ Open. 2019. PMID: 31076476 Free PMC article. Clinical Trial.
Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S, Almeida C, Ambler N, Blair PS, Choy E, Dures E, Hammond A, Hollingworth W, Kadir B, Kirwan J, Plummer Z, Rooke C, Thorn J, Turner N, Pollock J. Hewlett S, et al. Health Technol Assess. 2019 Oct;23(57):1-130. doi: 10.3310/hta23570. Health Technol Assess. 2019. PMID: 31601357 Free PMC article. Clinical Trial.
Test-guided dietary management of eczema in children: A randomized controlled feasibility trial (TEST).
Ridd MJ, Webb D, Roberts K, Santer M, Chalmers JR, Gilbertson A, Marriage D, Blair PS, Turner NL, Garfield K, Coast J, Selman LE, Clement C, Shaw ARG, Muller I, Waddell L, Angier E, Taylor J, Kai J, Boyle RJ. Ridd MJ, et al. Among authors: turner nl. Clin Exp Allergy. 2021 Mar;51(3):452-462. doi: 10.1111/cea.13816. Epub 2021 Jan 15. Clin Exp Allergy. 2021. PMID: 33386634 Clinical Trial.
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators. Kehoe PG, et al. Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5. Lancet Neurol. 2021. PMID: 34687634 Free PMC article. Clinical Trial.
56 results